OMNIPOD INSULIN MANAGEMENT SYSTEM
Report
- Report Number
- 3004464228-2022-17655
- Event Type
- Malfunction
- Date Received
- November 11, 2022
- Date of Event
- September 5, 2022
- Report Date
- September 12, 2022
- Manufacturer
- INSULET CORPORATION
- Product Code
- LZG
- PMA / PMN Number
- K192659
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MA, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
THE DEVICE WAS RETURNED NOT DEPLOYED. THE DOWNLOAD DATA SHOWS THE DEVICE COMPLETED 45 FIRST PRIME PULSES AND WAS THEN DEACTIVATED AFTER THE COMPLETION OF FIRST PRIME. DURING INVESTIGATION THE DEVICE DEPLOYED NORMALLY UPON MANUAL ROTATION OF THE RATCHET GEAR. NO DAMAGES OR DEFECTS WERE OBSERVED THAT WOULD RESULT IN A FAILURE OF THE CANNULA TO DEPLOY.D4 - SERIAL NO CHANGED FROM 0870884 TO 0670684. D4 - UNIQUE IDENTIFIER (UDI) # CHANGED FROM (B)(4).
WE ARE UNABLE TO CONFIRM THE REPORTED NEEDLE MECHANISM FAILURE OR DETERMINE ITS ROOT CAUSE. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS. PER SUPPORT TICKET-337500 ¿THE FDA CDRH APPLICATION TEAM RECOGNIZES THAT INDUSTRY FACED SUBMISSION ISSUES AND DELAY IN ACK3 RESPONSES DURING THE MONTH OF SEPTEMBER 2022.
IT WAS REPORTED THE NEEDLE DID NOT DEPLOY, INDICATING A FAILURE OF THE NEEDLE MECHANISM. THE PATIENT'S BLOOD GLUCOSE LEVELS WERE UNAFFECTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1285948 | OMNIPOD INSULIN MANAGEMENT SYSTEM | PUMP, INFUSION, INSULIN | LZG | INSULET CORPORATION | 19191 | L50307 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |